查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
失眠治疗市场:按治疗类型、按分销渠道、按地区 - 规模、份额、前景、机会分析，2022-2028
市场调查报告书
商品编码
1110117

失眠治疗市场:按治疗类型、按分销渠道、按地区 - 规模、份额、前景、机会分析，2022-2028

Insomnia Treatment Market, By Treatment Type, By Distribution Channel, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

失眠症或失眠症是一种睡眠障碍，使您难以入睡。体征和症状包括入睡困难和睡眠不安。有时会使用安眠药，但您应该注意它们的副作用。低剂量服用用于治疗抑郁症的处方药可缓解失眠。失眠的认知行为疗法（CBT-I）通常被推荐为一线治疗。 CBT-I 是一个系统程序，可帮助您识别导致或加剧睡眠障碍的想法和行为，并用促进更好睡眠的习惯取而代之。

市场动态:

由于睡眠障碍的高发病率、对安全有效治疗的需求不断增加、公众意识的提高以及全球人口老龄化的迅速增加，预计全球失眠治疗市场将在预测期内增长。老年人失眠的患病率高于年轻人。与衰老、慢性疾病和环境条件相关的生理变化会导致老年人失眠。因此，随着人口老龄化的增长，全球对安全有效的失眠治疗的需求也在增加。例如，根据世界卫生组织（WHO）的数据，到 2030 年，全球六分之一的人口将超过 60 岁，到 2050 年，世界 60 岁以上的人口将翻一番，达到 21 亿。

本研究的主要特点

  • 本报告对全球失眠治疗市场进行了深入分析，提供了以 2021 年为基准年的预测期（2022-2028 年）的市场规模和復合年增长率 (CAGR %)。
  • 解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
  • 它还提供有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争策略等方面的重要见解。
  • 它根据以下参数描述了全球失眠治疗市场的主要参与者，包括公司亮点、产品组合、关键亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括:Innovative Neurological Devices、Cereve Inc.、Sanofi SA、辉瑞公司、Patek Pharmaceuticals Inc.、默克公司、武田製药有限公司、Ebb Therapeutics 和 Electromedical产品国际公司等。
  • 本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 《全球失眠治疗市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
  • 利益相关者可以通过用于分析全球失眠治疗市场的各种战略矩阵来促进他们的决策。

第一章研究目标和先决条件

  • 调查目的
  • 先决条件
  • 缩写

第二章市场展望

  • 举报内容
    • 市场定义和范围
  • 执行摘要
    • 按治疗类型划分的鼻腔给药模式市场
    • 鼻给药方式市场:按分销渠道
    • 鼻腔给药模式市场:按地区划分
  • 连贯的机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 全球失眠症患病率不断上升
    • 抗失眠药物的典型副作用
    • COVID-19 爆发（持续大流行）
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/批准
  • PEST 分析
  • 对PORTER的分析
  • 併购方案

第 4 章失眠治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19 的流行病学
  • 供应方和需求方分析
  • 经济影响

第 5 章失眠治疗市场，按治疗类型，2017-2028 年

  • 药物
  • 设备

第 6 章失眠治疗市场:按分销渠道，2017-2028

  • 医院药房
  • 零售药房
  • 其他分销渠道

第 7 章。失眠药物市场:2017-2028 年各地区

  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
  • 世界其他地区

第 8 章竞争格局

  • Innovative Neurological Devices
  • Cereve Inc.
  • Sanofi SA
  • Pfizer Inc.
  • Paratek Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Ebb Therapeutics
  • Electromedical Products International Inc.

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI958

Insomnia, or sleeplessness, is a sleep disorder in which people have trouble sleeping. Signs and symptoms may include difficulty falling or staying asleep and not feeling well-rested. Sleeping pills may also be used, but should be monitored for side effects. Sometimes prescription drugs used to treat depression may ease insomnia when taken in lower doses. Cognitive behavioral therapy for insomnia, CBT-I, is usually recommended as the first line of treatment. CBT-I is a structured program that helps people identify and replace thoughts and behaviors that cause or worsen sleep problems with habits that promote sound sleep.

Market Dynamics:

High prevalence of sleep disorders, growing demand for safe and effective treatment, increase in awareness among people, and rapidly growing geriatric population worldwide is expected to augment the growth of the global insomnia treatment market during the forecast period. The prevalence of insomnia is higher in elderly than in the younger population. Physiologic changes of aging, chronic medical illnesses, and environmental conditions contribute to insomnia in the elderly. Thus, with the growing geriatric population, the demand for safe & effective insomnia treatment worldwide. For instance, according to the World Health Organization (WHO), one in six people in the world will be aged 60 years or over by 2030, and the world's population of people aged 60 years and older will double (2.1 billion) by 2050.

Key features of the study:

  • This report provides in-depth analysis of the global insomnia treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global insomnia treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Innovative Neurological Devices, Cereve Inc., Sanofi SA, Pfizer Inc., Paratek Pharmaceuticals Inc., Merck & Co. Inc., Takeda Pharmaceutical Company Ltd., Ebb Therapeutics, and Electromedical Products International Inc., among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global insomnia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global insomnia treatment market.

Detailed Segmentation:

Global Insomnia therapeutics Market, By Treatment Type:

  • Drug
  • Device

Global Insomnia therapeutics Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels

Global Insomnia therapeutics Market, By Geography:

  • North America
  • Europe
  • Asia-Pacific
  • Middle East & Africa
  • South America

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Insomnia Treatment, By Treatment Type
    • Market Insomnia Treatment, By Distribution Channel
    • Market Insomnia Treatment, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence of insomnia across the globe
    • Characteristic side effects of insomnia drugs
    • Outbreak of COVID-19 (ongoing pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Insomnia Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Insomnia Treatment Market, By Treatment Type, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Device
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Insomnia Treatment Market, By Distribution Channel, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
  • Other Distribution Channels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Insomnia Treatment Market, By Geography, 2017-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Middle East and Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
  • Rest of World
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

8. Competitive Landscape

  • Innovative Neurological Devices
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cereve Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Paratek Pharmaceuticals Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Takeda Pharmaceutical Company Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ebb Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Electromedical Products International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

9. Section

  • Research Methodology
  • About us